Divalproex Sodium Tablet, Delayed Release
Product Images NDC 55154-4154

7 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55154-4154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-divalproex-structure (Spl Divalproex Structure)

Spl-divalproex-structure (Spl Divalproex Structure)
Chemical structure of Divalproex Sodium showing the arrangement of carbon, hydrogen, oxygen, and sodium atoms in its molecular form, including branched alkyl chains and carboxylate groups.*
FDA Label Image

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)
A bar chart labeled Figure 1 comparing percentages for placebo (PBO) and Divalproex Sodium (DVPX) in two studies: Study 1 (YMRS) and Study 2 (MRS). The chart shows higher percentages for DVPX (60%, 58%) compared to PBO (26%, 29%) in both studies.*
FDA Label Image

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)
A cumulative percentage plot comparing the percentage reduction in CPS rate among patients using Divalproex Sodium (DVPX) versus placebo. The y-axis represents the percentage reduction in CPS rate from -100% (worsening) to 100% (improvement), and the x-axis shows the cumulative percentage of patients from 100% to 0%. Solid line corresponds to Divalproex Sodium and dashed line to placebo, illustrating the treatment effect distribution.*
FDA Label Image

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)
A cumulative distribution plot showing the percentage reduction in CPS rate for patients taking high and low doses of a drug. The x-axis represents the percentage of patients, decreasing from 100 to 0, and the y-axis shows the reduction in CPS rate from -100% to 100%. Two lines depict results for high dose (solid line) and low dose (dashed line) groups, with an annotation indicating improvement, no change, and worsening directions on the right side.*
FDA Label Image

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)
A bar chart titled 'Figure 4 Mean 4-week Migraine Rates' comparing migraine rates for Placebo and Divalproex Sodium (DVPX) groups across two studies. The vertical axis measures migraine rates from 0 to 6, showing lower mean migraine rates in DVPX groups compared to Placebo in both Study 1 and Study 2.*
FDA Label Image

250mg Bag Label (9fa8a32e 7def 4ae6 B537 15450ef34bc2 01)

250mg Bag Label (9fa8a32e 7def 4ae6 B537 15450ef34bc2 01)
Divalproex Sodium delayed-release tablets label showing 250 mg strength in a package of 10 tablets. The label includes dosage form as oral delayed-release tablets and details such as Valproic Acid activity, storage conditions, and a warning that the package is not child resistant and for institutional use only. It is labeled for retail by Cardinal Health 107, LLC, with additional packaging information from Major Pharmaceuticals.*
FDA Label Image

500mg Bag Label (9fa8a32e 7def 4ae6 B537 15450ef34bc2 00)

500mg Bag Label (9fa8a32e 7def 4ae6 B537 15450ef34bc2 00)
Divalproex Sodium delayed-release tablets, USP 500 mg, in a unit dose package containing 10 tablets. The label includes a barcode with NDC 55154-2336-0 and information specifying the pink tablets are imprinted with '798' in black ink. The product is for oral use, prescription only, and distributed by Cardinal Health 107, LLC and Major Pharmaceuticals, Indianapolis, IN. Storage instructions and warnings are also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.